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Abstract We describe the use of a phage-displayed random 
pentadecamer peptide library for searching glycosphingolipid 
mimicking peptides. Two phage clones (AD-1 and AD-2) were 
selected by biopanning using monoclonal antibody AD117m, 
directed to lactotetraosylceramide (Lc4Cer). The amino acid 
sequences of the selected clones showed high homology 
(VPPXFXXXY) in 9-mer. Three phage clones were selected by 
using monoclonal antibody Hl l , directed to neolactotetraosyl-
ceramide (nLc4Cer), the linkage isomer of Lc4Cer, and the 
displayed amino acid sequences were compared. One of these 
peptides showed the same amino acid sequence as that of AD-2 
except for one amino acid substitution. Pentadecamer, 9-mer and 
point mutated 9-mer peptides were synthesized on the basis of the 
displayed amino acid sequences. Binding activity of the peptides 
to the monoclonal antibodies or Ricinus communis lectin showed 
that 9-mer peptides are enough to mimic the epitope carbohy-
drate structure. Furthermore, six of the synthesized peptides 
inhibited Jack bean P-galactosidase activity towards nLc4Cer at 
a high concentration of the enzyme, whereas at lower enzyme 
concentrations some peptides showed potent activation of the 
enzyme activity. This is the first report of carbohydrate 
mimicking peptides which modulate glycosidase activity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The carbohydrate moiety of glycosphingolipids has impor-
tant roles in cell recognition by viruses and microorganisms 
[1-3], cell adhesion on inflammation and tumor metastasis [4-
7], and cell differentiation [8,9]. To clarify the functional role 
of glycosphingolipids, much experimental information is 
needed. There are some problems in obtaining ligand sugar 
chains; i.e. it is difficult to prepare glycosphingolipids from 
minute samples within a short time, purification of glyco-
sphingolipids is complicated, and synthesizing glycosphingo-
lipids needs specialized skills and expensive apparatus. 
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Abbreviations: Gal, galactose; GlcNAc, 7V-acetylglucosamine; 
Lc3Cer, GlcNAcpi ^3Gaipi ^4Glcpi -> ICer; Lc4Cer, Gaipi ^3Glc-
NAcpi^3Gaip i^4Glc |51^1Cer ; nLc4Cer, Galp l^4Glc-
NAcpi->3Gaipi->4Glcpi->lCer; PBS, phosphate buffered saline; 
TLC, thin-layer chromatography 
Recently, epitopes which are recognized by monoclonal 
antibodies have been determined by using a phage-displayed 
random peptide library [10-13]. Some papers indicate the 
phage library is available for preparation of peptides which 
mimic carbohydrate structures by using monoclonal antibod-
ies directed to sugar chains [14-16]. 
We used a phage-displayed 15-mer random peptide library 
[17] and two monoclonal antibodies which recognize respec-
tively lactotetraosylceramide (Lc4Cer) and its isomer glyco-
sphingolipid neolactotetraosylceramide (nLc4Cer) for prepara-
tion of peptides which mimic carbohydrate moieties of two 
glycosphingolipids. We selected phage clones having specific 
affinity against individual antibodies and investigated the 
binding of antibodies and a lectin to synthesized 15-mer and 
9-mer peptides. In order to examine if the peptides actually 
mimic the biological function of glycosphingolipids, we also 
studied the modulation properties of the peptides on [3-galac-
tosidase activity. 
2. Materials and methods 
2.1. Phage-displayed random peptide library 
The pentadecamer random peptide library displayed on a filamen-
tous phage (fd phage) surface protein (pill) was constructed as de-
scribed previously [17]. The library has 2.5 XlO8 recombinants. 
2.2. Selection of peptides which mimic the carbohydrate moiety of 
Lcj Cer and nLcj Cer (biopanning) 
Biopanning was done against anti-Lc4Cer monoclonal antibody 
(AD117m) and anti-nLc4Cer monoclonal antibody (Hll). 400 ug of 
antibody in 200 ul of 50 mM NaHC03, pH 8.8 was biotinylated by 
incubation with 210 ug of sulfo-NHS-biotin (Pierce, Rockford, IL) 
overnight at 4°C. Each biotinylated antibody was adsorbed onto a 
streptavidin-coated polystyrene Petri dish (10 ug/35 mm), and the 
Petri dish was treated with blocking solution (100 mM NaHCC>3, 
5 mg/ml BSA, 0.1 ug/ml streptavidin, and 0.02% NaN3) for 1 h at 
room temperature. Affinity selection of phage clones from the random 
peptide library was carried out as described by Scott and Smith [10]. 
The phage library (2.5 X 1010 titer) in 100 ul of PBS was added to the 
antibody-coated dishes, and incubated overnight at 4°C. After this, 
each dish was washed with PBS to remove free phage clones and the 
phage clones bound to the antibody were eluted with elution buffer 
(0.1 N HC1, pH 2.2 containing 1 mg/ml BSA). Each eluate was neu-
tralized, concentrated with Centricon-30 concentrator (Amicon), and 
the obtained phage clones were amplified by infecting them to host 
bacterial cells (Escherichia coli K91Kan). The amplified phage clones 
were reacted with the monoclonal antibody-coated Petri dish again. 
After three cycles of biopanning the selected phage clones were sub-
jected to DNA sequence analysis. 
2.3. DNA sequence 
Phage from supernatants of positive colonies were precipitated with 
polyethylene glycol (PEG 6000), and their single strand DNA was 
prepared by phenol extraction. The DNA sequence of the positive 
phage clones obtained from biopanning was determined by dideoxy-
nucleotide chain termination. An oligonucleotide 5'-TAACACT-
GAGTTTCGTCACCAGTA was used as an antisense primer. Each 
amino acid sequence was deduced from the DNA sequence. 
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2.4. Inhibition of antibody binding by selected phage clones and 
synthetic peptides 
Monoclonal antibody (AD 117m, 1 ug) was incubated with selected 
phage clones or synthetic peptides indicated in Table 2 overnight at 
4°C. After this, the mixture was transferred to a Lc4Cer-coated poly-
styrene 96-well microtiter plate and left overnight at 4°C. After wash-
ing the plate with PBS several times, bound AD 117m was determined 
with peroxidase-conjugated anti-mouse IgM antibody. The bound 
antibody was monitored by peroxidase activity, with orthophenyldi-
amine used as substrate, and the color developed was determined by a 
microtiter plate reader at 490 nm. 
2.5. Binding of monoclonal antibody and lectin to synthesized peptides 
Pentadecamer and 9-mer peptides indicated in Table 2 were synthe-
sized (Peptide institute, Inc. Osaka) and their specificity for binding to 
monoclonal antibodies and Ricinus communis lectin, which recognizes 
the non-reducing terminal P-galactose of carbohydrate, was deter-
mined. Various amounts of individual peptides were coated on the 
bottom of a Multiscreen Immobilon-P Filtration plate (MAIP N45, 
Millipore, Molsheim, France). 1 ug of monoclonal antibodies or per-
oxidase-conjugated lectin was added in each well in 50 ul of PBS and 
left on the plate overnight at 4°C. After washing the plate with PBS, 
the bound antibodies or lectin were monitored by peroxidase activity 
with the Konica Immunostaining kit (Konica Co., Tokyo). Peroxi-
dase-conjugated anti-mouse IgM was used as second antibody. 
2.6. Effect of peptides on fi-galactosidase activity 
Jack bean p-galactosidase was incubated in the presence of various 
amounts of synthetic peptides in 20 ul of 0.1 M acetate buffer, pH 
4.5 at 37°C using nLQCer as a substrate. After the incubation, the 
reaction mixture was air dried, the residue was dissolved in 10 ul of 
chloroform:methanol (2:1, v/v), and subjected to TLC. Chloro-
form:methanol:0.2% CaCl2 (60:30:8, v/v) was used as developing 
solvent mixture. After this, glycosphingolipids were made visible by 
spraying the plate with orcinol reagent. The enzyme activity was de-
termined by monitoring the incubation product (LcjCer) with a den-
sitograph (ATTO Co. Ltd., Tokyo). 
3. Results and discussion 
To develop a new approach to clarify the functional roles of 
glycoconjugates, we tried to prepare peptides which mimic the 
carbohydrate structure of glycosphingolipids using a phage-
displayed random peptide library. The library is a vast mix-
ture of filamentous phage clones each displaying a 15-mer 
peptide on a virion surface protein (pill) [17]. The phage 
were reacted with biotinylated monoclonal antibody 
AD 117m directed to Lc^Cer, then placed on a streptavidin-
coated plastic surface, thereby specific binding of the anti-
body-reactive phage to the plastic surface through the bio-
tin-streptavidin bridge took place [10]. Free phage clones 
were washed away and bound clones were recovered in acid 
solution, and allowed to infect E. coli K91Kan. After repeat-
Table 1 
Amino acid sequences (deduced from the DNA sequences) of 15-
mer peptides expressed on pill protein from selected phage clones 
by biopanning with anti-Lc4Cer antibody (AD117m) and anti-
nLc4Cer antibody (HI 1) 
Consensus 
AD-1 
AD-2 
Hll-1 
HI 1-2 
Hll-3 
VPPXFXXXY 
RNVPPTFNDVYWIAF 
VPPCFTLMYCAGVVR 
FRSFHYHTGRWHWLR 
RNVPPIFNDVYWIAF 
ARFPKELRGSVRSAH 
AD-1 and -2 are peptides obtained from selected phage clones by 
biopanning with AD 117m. Hll-1, -2, and -3 are peptides obtained 
from selected phage clones by biopanning with HI 1. Consensus amino 
acids are underlined. 
o.oi 
Phage (nM) 
Fig. 1. Inhibition of antibody binding by selected phage clones, 
AD-1 and AD-2. Monoclonal antibody AD 117m was incubated 
with serially diluted phage solutions at 4°C overnight. The mixture 
was transferred to a Lc4Cer-coated microtiter plate and left at 4°C 
overnight. After washing the plate with PBS, bound monoclonal 
antibody was determined with peroxidase-conjugated anti-mouse 
IgM antibody. Phage concentration was determined by measuring 
the absorbance at 264 nm. 
ing this biopanning three times, two phage clones were ob-
tained. They were named AD-1 and AD-2, respectively. These 
two clones showed a potent inhibitory effect on the binding of 
the monoclonal antibody to Lc4Cer coated on a 96-well mi-
crotiter plate (Fig. 1). The peptide sequences expressed on 
each pill protein of individual phage clones were determined 
by sequencing the DNA encoding the inserted region into the 
pill protein. The deduced amino acid sequences of AD-1 and 
AD-2 are shown in Table 1. Nonamers of these two 15-mer 
peptides show significant homology. 
Lc4Cer is a linkage isomer of paragloboside (nLc4Cer). The 
sugar sequences of these two glycosphingolipids are the same. 
The non-reducing terminal of P-Gal is linked at the 3 position 
of the penultimate GlcNAc in LC4Cer; on the other hand, the 
Gal in nLc4Cer is linked to the GlcNAc of lactotriaosylcer-
amide (LcsCer) through 1 -»4 linkage. To compare the amino 
acid sequences of Lc4Cer mimicking peptides with those of 
nLc4Cer, we selected phage clones using the monoclonal anti-
body H l l , directed to nLc4Cer [18]. Three phage clones, 
named Hl l -1 , -2, and -3, were obtained and their amino 
acid sequences, determined from DNA sequencing of the 
pill protein, are shown in Table 1. Interestingly, the peptide 
sequence of AD-2 is almost the same as that of HI 1-2. Only 
one amino acid, isoleucine, is replaced by tyrosine in HI 1-2. 
But the other two peptide sequences are completely different 
from those of AD-1 and AD-2. On the basis of these amino 
acid sequences of the selected phage, we synthesized the pep-
tides listed in Table 2. Three kinds of 9-mer peptides showed 
binding activity to the antibody indicating that peptide 9-mer 
is enough to mimic the carbohydrate structure of antigen 
glycosphingolipid. In Table 2, the amounts of individual pep-
tide required for 50% inhibition of the binding of antibody 
AD 117m to immobilized Lc4Cer on a microtiter plate are 
shown. For the inhibition of the binding, large amounts of 
peptides are required in each case compared to those for the 
binding experiment. This phenomenon seems to be similar to 
inhibition by epitope oligosaccharide. For the inhibition of 
antigen-antibody reaction, epitope oligosaccharide is required 
in a more than 1000-fold concentration compared with that of 
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Fig. 2. Inhibition of Jack bean p-galactosidase activity by the pepti-
des. A: Incubation mixture contained 5 ug of nLc4Cer, 10 mU of 
Jack bean P-galactosidase, and 50 |ig of peptide in 20 ill of 0.1 M 
acetate buffer, pH 4.5. Incubation was done at 37°C for 2 h. Ali-
quots of the mixture was subjected to TLC and glycosphingolipids 
were made visible by spraying the plate with orcinol reagent. The 
enzyme activity was determined by measuring the incubation prod-
uct (Lc3Cer) with a densitometer (Densitograph, ATTO Co., Ltd., 
Tokyo). B: Dose-dependent inhibition of Jack bean P-galactosidase 
by a nLc4Cer replica peptide, HI 1-1-15. 
antigen glycosphingolipid. Two-dimensional proton NMR 
analyses of 15- and 9-mer peptides did not display a stable 
three-dimensional conformation (data not shown), indicating 
that these peptides, especially in the aqueous layer, change 
their steric conformations freely, and the frequency to form 
a structure mimetic to the epitope is quite low. However, 
when these peptides were immobilized on a solid phase such 
as silica beads, or displayed on a membrane protein pill, the 
structures seem to be very similar, sufficient to bind to anti-
body (Table 2 and Fig. 1). 
To confirm that these peptides really mimic the carbohy-
drate structures of antigen glycosphingolipids, we examined 
the binding of Ricinus communis lectin, which recognizes the 
terminal (3-Gal, preferentially the structure of Gal(31->4Glc-
NAc of glycoconjugates. Binding assay by the overlay proce-
dure showed binding of the lectin to AD-2-15 as well as H l l -
3-15. Although binding of the lectin to Hll-1-15 and Hl l -3-
15 was weaker than that to HI 1-2-15, the results of the bind-
ing study to lectin and monoclonal antibody strongly sug-
gested that the peptides obtained by the present procedure 
closely mimic the epitope structure of glycosphingolipid anti-
gen. 
Having carbohydrate mimetic structure with P-Gal at the 
non-reducing end, these peptides may have affinity to p-gal-
actosidase. nLc<iCer is a substrate of Jack bean P-galactosi-
dase. We examined whether these peptides have an effect on 
the activity of Jack bean P-galactosidase. In general, deter-
gents are required for the activation of glycosidase reaction 
[19], but in the present study, we did not add any detergent to 
simplify the effect of the peptides. Several peptides showed an 
inhibitory effect, and the inhibition was dose-dependent (Fig. 
2A). When the concentration of peptide was equivalent to 
that of substrate, more than 50% inhibition was observed, 
indicating that each peptide has a potent inhibitory effect on 
p-galactosidase. We tried to clarify the inhibition mechanism, 
but the reaction velocity showed a sigmoid curve in associa-
tion with substrate concentration (Fig. 2B) and also with en-
zyme concentration. This is because nLc4Cer easily makes 
micelles in the aqueous layer. Although the inhibition mech-
anism could not be clarified, the peptides showing inhibitory 
effects also have binding affinity to each monoclonal antibody 
suggesting that these peptides competed with nLc4Cer for 
substrate binding site(s) of the enzyme. On the other hand, 
quite interestingly, some of these peptides showed a potent 
Table 2 
Synthesized amino acid sequences of 15-mer and 9-mer peptides, and their specificity for binding to the monoclonal antibodies and lectin 
Amino acid sequence AD117m(iig)a Hll (ug)a IH5o(AD117m)(ng/ml) R. communis lectin (ug)
a 
AD-2-9a 
AD-2-9b 
AD-2-9c 
AD-2-9d 
AD-2-9e 
AD-1-9 
AD-1-15 
HI 1-2-9 
Hll-2-15 
Hll-1-15 
Hll-3-15 
VPPYFTLMY 
VPPCFTLMY 
VPPTFTLMY 
VPPAFTLMY 
VPPSFTLMY 
VPPTFNDVY 
RNVP PT FNDVYWIAF 
VPPIFNDVY 
RNVPPIFNDVYWIAF 
FRGFHYHTGRWHWLR 
ARFPKELRGSVRSAH 
2 
8 
8 
nd 
nd 
nd 
0.125 
nd 
0.25 
nd 
nd 
8 
8 
8 
nd 
nd 
nd 
0.5 
nd 
0.5 
nd 
nd 
540 
150 
270 
1800 
600 
1600 
130 
>5000 
330 
1600 
>5000 
2 
nd 
nd 
nd 
4 
nd 
2 
nd 
nd 
a Amount of peptide required for binding of antibody and lectin. 
nd, not detected. 
IH50 (AD 117m) is the amount of each peptide required for 50% inhibition of the binding between Lc4Cer and AD 117m. 
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Fig. 3. Activation of Jack bean P-galactosidase activity by the addition of Lc4Cer and nLc4Cer replica peptides. The incubation mixture con-
tained 10 u.g of nLc4Cer, 10 u.g of each peptide and the indicated amounts of enzyme in 20 ul of 0.1 M acetate buffer, pH 4.5. Incubation was 
done at 37°C for 30 min. A: TLC profiles of the incubation products (LcgCer) are shown. B: Activation profile at a concentration of 1 mU of 
enzyme using 10 (ig of each peptide. 
activation effect on the enzyme activity as shown in Fig. 3. 
When the enzyme concentration was less than 5 mU/20 u], no 
incubation product was detected, but large amounts of Lc3Cer 
and Gal were produced by the addition of HI 1-3-15, AD1-15, 
AD-2-9b, or AD2-9c peptide. 
Although the mechanisms of activation and inhibition are 
difficult to clarify at the present time, an excess amount of the 
peptide seems to compete for the substrate binding site with 
nLdCer resulting in inhibition, and suitable amounts of sub-
strate mimetic peptides may rather activate the enzyme to 
react to the micelle form of the substrate. It is well known 
that sufficient substrate is necessary to stimulate the enzyme 
reaction, and the addition of substrate mimetic peptide could 
make such a circumstance. 
The activation mechanism of HI 1-3-15 showed no inhibi-
tory effect at any incubation conditions used. The activation 
manner looks like an effector which binds to the activator site 
of the allosteric enzyme. Although we have no evidence that 
this enzyme is an allosteric enzyme, this kind of activator 
seems to be useful for future study of the enzyme regulation 
mechanism and also for a possible application to the therapy 
of glycosphingolipid storage disease. The present paper em-
T. Taki et al.lFEBS Letters 418 (1997) 219-223 223 
phasizes the following items. (1) Possible preparat ion of pep-
tides which mimic carbohydrate structure using phage-dis-
played random peptide library. (2) The functional roles of 
carbohydrate can be replaced by carbohydrate mimetic pep-
tides. (3) Unexpected physiological activities such as inhibi-
tion or activation of enzymes could be searched for using 
carbohydrate mimetic peptides. A new approach for searching 
for functional roles of glycoconjugates will be opened by the 
present method. We want to propose using the term glyco-
replica peptide for carbohydrate mimetic peptides. 
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